Departing employee will still receive $700,000 salary, company's shares drop on news
Moderna Inc. has announced that chief financial officer Jorge Gomez has left the COVID-19 vaccine maker after just one day following an internal investigation at his former employer.
Dentsply Sirona Inc., a dental equipment manufacturer, has disclosed an internal investigation of financial reporting matters, Bloomberg reported. On Tuesday, Dentsply said that its audit and finance committee is investigating allegations around the company’s use of incentives to sell products to distributors and other actions to achieve executive compensation targets.
Moderna said it learned about the probe through Dentsply’s regulatory filing. Gomez was Dentsply’s CFO for almost three years.
Read more: Why new vaccine fund is one to watch
“The investigation is ongoing, and the company cannot predict the duration or outcome of the investigation,” said the filing. “As a result, the company has not yet finalized its financial statements or its assessment of the impact of the investigation on its historical financial statements or for the financial statements for the three months ended March 31, 2022, and is therefore unable to file the Form 10-Q on a timely basis.”
David Meline, Moderna’s recently retired finance chief, will serve in the role while the company searches for a new CFO, MarketWatch reported. Moderna hired Gomez in April, with CEO Stephane Bancel citing his passion for sustainability that aligned with the company’s vision of corporate responsibility as a key part of its mission.
Although Gomez will still receive a year’s salary totaling $700,000, he’ll forfeit his signing bonus and bonus eligibility, Moderna said.
Moderna's shares fell 1.2% during morning trading in New York.
